Aluvis International, Inc.
Biotechnology company · Milwaukee, Wisconsin, United States
Aluvis International, Inc. is a biotechnology company headquartered in Milwaukee, Wisconsin, United States. Its earliest recorded incorporation is in 2018. It has reported private securities offerings to the US SEC, most recently $649,999 sold in a notice filed in 2020.
Aluvis International at a glance
What does Aluvis International do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $649,999 sold (2020).
Frequently asked questions about Aluvis International
Where is Aluvis International headquartered?
Aluvis International, Inc. is headquartered in Milwaukee, Wisconsin, United States.
What does Aluvis International do?
Aluvis International, Inc. is a biotechnology company.
When was Aluvis International founded?
The earliest incorporation on record for Aluvis International, Inc. is in 2018, according to public company registers.
Similar companies
- 3D Molecular Designs, LLCMilwaukee, Wisconsin, United States
- Function Therapeutics IncMilwaukee, Wisconsin, United States
- Cell Reprogramming & Therapeutics LLCMilwaukee, Wisconsin, United States
- Up Oncolytics, Inc.Milwaukee, Wisconsin, United States
- GenoPalate, Inc.Milwaukee, Wisconsin, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences